Medeon Biodesign, Inc.

NT$70.90As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6499Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (3.24%)
Div yield —
ROE (28.19%)
Medical Instruments & Supplies
Beta (5Y) 0.65
PE TTM —
TSR TTM (32.15%)
Mkt cap NT$6.873B
ROIC (16.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$89
25.16%
5.98%
Hold 11|3|10|1|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.32
1.33
1.47
1.46
21.55%
10.42%
24.67%
10.69%
RevenueNT$M
696.2
715.7
696.3
701.5
17.81%
17.00%
10.62%
6.64%
Peers (US$207.6M)
Cap (US$)
PE
217.7M
12.30x
161.6M
12.53x
156.9M
11.85x
208.9M
10.22x
Capital
TTM
5Y
10Y
Leveragex
0.277
1.059
0.756
EBIT/Intx
0.746
0.185
0.183
Own earn%
(55.34)
40.14
47.41
Sh yield%
29.46
28.79
29.27
Owners
Insiders/Inst%
11.05
87.06
Short interest%
3.50
SBC / revenue%
1.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
16–19
$1 testx
−0.3
Incr. ROIC%
2